New Enterprise Ventures is a consulting firm specializing in delivering transformative strategy and business development to accelerate penetration in the US healthcare market. We are uniquely positioned to guide early-stage companies and industry leaders to make better-informed business decisions that require both technical insight and unsurpassed access to cutting-edge technologies and economic buyers.
We offer end-to-end integrated services including strategy, business development, and executive placement. Our extensive experience and pedigree in the healthcare marketplace provide us with unique insight into aligning corporate strategy with execution, including navigating the burgeoning world of data and analytics, making more informed buy, build and license decisions on emerging technologies, and delivering strategic partners that drive sales and revenue.
Our advisory board is composed of premiere professionals representing critical areas across the healthcare continuum.
Learn more about the expertise each of our board members can bring to our clients.
Syntegra, the leader in generating synthetic healthcare data, and Datavant, the leader in helping organizations securely connect health data, today announced a partnership integrating Syntegra’s synthetic data capabilities into Privacy Hub in the Datavant Switchboard, a neutral, trusted and ubiquitous infrastructure for the exchange of privacy-preserved health data.
Philadelphia, PA – December 19, 2022 – New Enterprise Ventures (NEV) recently announced the launch of IntelliSynch, a rapid decision support solution for validating and optimizing ideas, products and strategies with senior level executives across healthcare verticals.
Who will be the DPHARM Idol Disrupt 2022 winner? Donna Usiskin, NEV Chief Strategy Officer along with an elite group industry experts will be providing the questions and judging the answers at the upcoming 2022 DPharm conference.
Boehringer Ingelheim Pharmaceuticals Inc. and HealthPrize announced statistically significant results from a retrospective observational study that showed 44% greater medication adherence for patients that self-enrolled in the RespiPoints program, compared to matched patients not enrolled in the program.
Syntegra, the leader in generating synthetic healthcare data, and Datavant, the leader in helping organizations securely connect health data, today announced a partnership integrating Syntegra’s synthetic data capabilities into Privacy Hub in the Datavant Switchboard, a neutral, trusted and ubiquitous infrastructure for the exchange of privacy-preserved health data.
Philadelphia, PA – December 19, 2022 – New Enterprise Ventures (NEV) recently announced the launch of IntelliSynch, a rapid decision support solution for validating and optimizing ideas, products and strategies with senior level executives across healthcare verticals.
Who will be the DPHARM Idol Disrupt 2022 winner? Donna Usiskin, NEV Chief Strategy Officer along with an elite group industry experts will be providing the questions and judging the answers at the upcoming 2022 DPharm conference.
